This compound is a derivative of N-methyl-L-valine used as a protecting reagent in peptide synthesis. It features the Fmoc (9-fluorenylmethoxycarbonyl) group, which temporarily protects the amino group during solid-phase peptide assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 84000-11-3
Fmoc-N-methyl-L-isoleucine
pharmaceutical intermediate
Fmoc-N-methyl-L-alloisoleucine
research compound
Fmoc-N-Methyl-L-alanine
pharmaceutical intermediate
Boc-Glycine
pharmaceutical intermediate
Chitosan, 2-hydroxypropyl ether
pharmaceutical intermediate
Diphenylmethylpiperazine
pharmaceutical intermediate
5-Chloro-2-methyl-1-phenyl-1H-benzimidazole
pharmaceutical intermediate
2-Methylpropaneboronic acid (1S,2S,3R,5S)-(+)-2,3-pinanediol ester
pharmaceutical intermediate
(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-methylbutanoic acid
YCXXXPZNQXXRIG-IBGZPJMESA-N
CC(C)[C@@H](C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13